Stock listing
Hls Therapeutics, Inc.
Selected listing: A2JGH0 · LS · EUR · DE
Hls Therapeutics, Inc. (Lang & Schwarz: A2JGH0), Health Technology. Latest release Oct 2, 2026: HLS Therapeutics : Investor Presentation Fall 2026.
- Ticker
- Lang & Schwarz: A2JGH0
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Lang & Schwarz
- Currency
- EUR
About Hls Therapeutics, Inc.
HLS Therapeutics, Inc. is a publicly traded company on the Canadian market under the ticker HLS. HLS Therapeutics focuses on developing and commercializing innovative pharmaceutical products.
Latest news from Hls Therapeutics, Inc.
HLS Therapeutics : Investor Presentation Fall 2026
October 2, 2026
HLS Therapeutics Announces Board of Directors Changes
October 1, 2026
HLS Therapeutics Increases Normal Course Issuer Bid
September 24, 2026
HLS Therapeutics Announces Q2 2026 Financial Results
August 12, 2026
HLS Therapeutics Provides Update on NILEMDO™ Market Access
August 5, 2026
Events
Research Hls Therapeutics, Inc.
Hls Therapeutics, Inc. company profile
View the public company page for Hls Therapeutics, Inc. on 6ix.
Hls Therapeutics, Inc. news
Read company news and market updates connected to Hls Therapeutics, Inc..
Hls Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Hls Therapeutics, Inc..
Alternate listings
HLS:TSX
CA · CAD
Alternate listing for Hls Therapeutics, Inc.; the primary context on this page is A2JGH0:LS.
HLTRF:OTC
US · USD
Alternate listing for Hls Therapeutics, Inc.; the primary context on this page is A2JGH0:LS.
A2JGH0:LSX
DE · EUR
Alternate listing for Hls Therapeutics, Inc.; the primary context on this page is A2JGH0:LS.
74D:FWB
DE · EUR
Alternate listing for Hls Therapeutics, Inc.; the primary context on this page is A2JGH0:LS.
HLS:NEO
CA · CAD
Alternate listing for Hls Therapeutics, Inc.; the primary context on this page is A2JGH0:LS.